Targeting tetraspanins in cancer

Bibliography

• Andersen MH, Junker N, Ellebaek E, Therapeutic cancer vaccines in combination with conventional therapy. J Biomed Biotechnol 2010;2010:237623
   PubMedGoogle Scholar
• Blanco E, Hsiao A, Ruiz-Esparza GU, Molecular-targeted nanotherapies in cancer: enabling treatment specificity. Mol Oncol 2011;5:492-503
   PubMed Web of Science ®Google Scholar
• Scott AM, Wolchok JD, Old LJ. Antibody therapy of cancer. Nat Rev Cancer 2012;12:278-87
   PubMed Web of Science ®Google Scholar
• Leibovici J, Itzhaki O, Huszar M, Sinai J. The tumor microenvironment: part 1. Immunotherapy 2011;3:1367-84
   Google Scholar
• Hanna E, Quick J, Libutti SK. The tumour microenvironment: a novel target for cancer therapy. Oral Dis 2009;15:8-17
   PubMed Web of Science ®Google Scholar
• Kohler G, Milstein C. Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion. Eur J Immunol 1976;6:511-19
   PubMed Web of Science ®Google Scholar
• Winter G, Harris WJ. Humanized antibodies. Immunol Today 1993;14:243-6
   PubMedGoogle Scholar
• Chan AC, Carter PJ. Therapeutic antibodies for autoimmunity and inflammation. Nat Rev Immunol 2010;10:301-16
   PubMed Web of Science ®Google Scholar
• Hemler ME. Targeting of tetraspanin proteins--potential benefits and strategies. Nat Rev Drug Discov 2008;7:747-58
   PubMed Web of Science ®Google Scholar
• Yanez-Mo M, Barreiro O, Gordon-Alonso M, Tetraspanin-enriched microdomains: a functional unit in cell plasma membranes. Trends Cell Biol 2009;19:434-46
   PubMed Web of Science ®Google Scholar
• Charrin S, le Naour F, Silvie O, Lateral organization of membrane proteins: tetraspanins spin their web. Biochem J 2009;420:133-54
   PubMed Web of Science ®Google Scholar
• Boucheix C, Rubinstein E. Tetraspanins. Cell Mol Life Sci 2001;58:1189-205
   PubMed Web of Science ®Google Scholar
• Greco C, Bralet MP, Ailane N, E-cadherin/p120-catenin and tetraspanin Co-029 cooperate for cell motility control in human colon carcinoma. Cancer Res 2010;70:7674-83
   PubMed Web of Science ®Google Scholar
• Zoller M. Tetraspanins: push and pull in suppressing and promoting metastasis. Nat Rev Cancer 2009;9:40-55
   PubMed Web of Science ®Google Scholar
• Chaput N, Thery C. Exosomes: immune properties and potential clinical implementations. Semin Immunopathol 2011;33:419-40
   PubMed Web of Science ®Google Scholar
• Valadi H, Ekstrom K, Bossios A, Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007;9:654-9
   PubMed Web of Science ®Google Scholar
• Hemler ME. Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol 2005;6:801-11
   PubMed Web of Science ®Google Scholar
• Levy S, Shoham T. The tetraspanin web modulates immune-signalling complexes. Nat Rev Immunol 2005;5:136-48
   PubMed Web of Science ®Google Scholar
• Audran R, Drenou B, Wittke F, Internalization of human macrophage surface antigens induced by monoclonal antibodies. J Immunol Methods 1995;188:147-54
   Google Scholar
• Chometon G, Zhang ZG, Rubinstein E, Dissociation of the complex between CD151 and laminin-binding integrins permits migration of epithelial cells. Exp Cell Res 2006;312:983-95
   PubMed Web of Science ®Google Scholar
• Nishiuchi R, Sanzen N, Nada S, Potentiation of the ligand-binding activity of integrin alpha3beta1 via association with tetraspanin CD151. Proc Natl Acad Sci USA 2005;102:1939-44
   PubMed Web of Science ®Google Scholar
• Hassuna N, Monk PN, Moseley GW, Partridge LJ. Strategies for targeting tetraspanin proteins: potential therapeutic applications in microbial infections. Bio Drugs 2009;23:341-59
   Google Scholar
• Barreiro O, Zamai M, Yanez-Mo M, Endothelial adhesion receptors are recruited to adherent leukocytes by inclusion in preformed tetraspanin nanoplatforms. J Cell Biol 2008;183:527-42
   PubMed Web of Science ®Google Scholar
• Hemler ME. Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Annu Rev Cell Dev Biol 2003;19:397-422
   PubMed Web of Science ®Google Scholar
• Monk PN, Partridge LJ. Tetraspanins - gateways for infection. Infect Disord Drug Targets 2012;12:4-17
   Google Scholar
• Barreiro O, Yanez-Mo M, Sala-Valdes M, Endothelial tetraspanin microdomains regulate leukocyte firm adhesion during extravasation. Blood 2005;105:2852-61
   PubMed Web of Science ®Google Scholar
• Yang C, Robbins PD. The roles of tumor-derived exosomes in cancer pathogenesis. Clin Dev Immunol 2011;2011:842849
   PubMed Web of Science ®Google Scholar
• Ristorcelli E, Beraud E, Verrando P, Human tumor nanoparticles induce apoptosis of pancreatic cancer cells. FASEB J 2008;22:3358-69
   Google Scholar
• Filipazzi P, Burdek M, Villa A, Recent advances on the role of tumor exosomes in immunosuppression and disease progression. Semin Cancer Biol 2012;22:342-9
   PubMed Web of Science ®Google Scholar
• Somasundaram R, Herlyn M. Melanoma exosomes: messengers of metastasis. Nat Med 2012;18:853-4
   Google Scholar
• Berthier-Vergnes O, Kharbili ME, de la Fouchardiere A, Gene expression profiles of human melanoma cells with different invasive potential reveal TSPAN8 as a novel mediator of invasion. Br J Cancer 2011;104:155-65
   Google Scholar
• Tarasova NI, Rice WG, Michejda CJ. Inhibition of G-protein-coupled receptor function by disruption of transmembrane domain interactions. J Biol Chem 1999;274:34911-15
   PubMed Web of Science ®Google Scholar
• Charrin S, Manie S, Oualid M, Differential stability of tetraspanin/tetraspanin interactions: role of palmitoylation. FEBS Lett 2002;516:139-44
   PubMed Web of Science ®Google Scholar
• Takeda T, Hattori N, Tokuhara T, Adenoviral transduction of MRP-1/CD9 and KAI1/CD82 inhibits lymph node metastasis in orthotopic lung cancer model. Cancer Res 2007;67:1744-9
   PubMed Web of Science ®Google Scholar
• Krause G, Patz M, Isaeva P, Action of novel CD37 antibodies on chronic lymphocytic leukemia cells. Leukemia 2012;26:546-9
   PubMed Web of Science ®Google Scholar
• Kaminski MS, Fig LM, Zasadny KR, Imaging, dosimetry, and radioimmunotherapy with iodine 131-labeled anti-CD37 antibody in B-cell lymphoma. J Clin Oncol 1992;10:1696-711
   PubMed Web of Science ®Google Scholar
• Jaglowski SM, Alinari L, Lapalombella R, The clinical application of monoclonal antibodies in chronic lymphocytic leukemia. Blood 2010;116:3705-14
   PubMed Web of Science ®Google Scholar
• Zhao X, Lapalombella R, Joshi T, Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical. Blood 2007;110:2569-77
   PubMed Web of Science ®Google Scholar
• Jin L, Cambier JC. SMIP-016 in Action: CD37 as a Death Receptor. Cancer Cell 2012;21:597-8
   PubMed Web of Science ®Google Scholar
• Lapalombella R, Yeh YY, Wang L, Tetraspanin CD37 Directly Mediates Transduction of Survival and Apoptotic Signals. Cancer Cell 2012;21:694-708
   PubMed Web of Science ®Google Scholar
• Robak T, Robak P, Smolewski P. TRU-016, a humanized anti-CD37 IgG fusion protein for the potential treatment of B-cell malignancies. Curr Opin Investig Drugs 2009;10:1383-90
   PubMed Web of Science ®Google Scholar
• Schnaiter A, Stilgenbauer S. Refractory chronic lymphocytic leukemia--new therapeutic strategies. Oncotarget 2010;1:472-82
   Google Scholar
• Phase I/Ib Study of TRU-016 in Patients With Previously Treated CLL or Select Subtypes of Non-Hodgkin's Lymphoma. 2012. Avaulable from http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00614042
   Google Scholar
• Heider KH, Kiefer K, Zenz T, A novel Fc-engineered monoclonal antibody to CD37 with enhanced ADCC and high proapoptotic activity for treatment of B-cell malignancies. Blood 2011;118:4159-68
   PubMed Web of Science ®Google Scholar
• Sincock PM, Mayrhofer G, Ashman LK. Localization of the transmembrane 4 superfamily (TM4SF) member PETA-3 (CD151) in normal human tissues: comparison with CD9, CD63, and alpha5beta1 integrin. J Histochem Cytochem 1997;45:515-25
   PubMedGoogle Scholar
• Kwon MJ, Park S, Choi JY, Clinical significance of CD151 overexpression in subtypes of invasive breast cancer. Br J Cancer 2012;106:923-30
   Google Scholar
• Ke AW, Shi GM, Zhou J, Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma. Hepatology 2009;49:491-503
   PubMed Web of Science ®Google Scholar
• Lin PC, Lin SC, Lee CT, Dynamic change of tetraspanin CD151 membrane protein expression in colorectal cancer patients. Cancer Invest 2011;29:542-7
   PubMed Web of Science ®Google Scholar
• Semenza GL. Does loss of CD151 expression promote the metastasis of hypoxic colon cancer cells? Clin Cancer Res 2008;14:7969-70
   PubMedGoogle Scholar
• Chien CW, Lin SC, Lai YY, Regulation of CD151 by hypoxia controls cell adhesion and metastasis in colorectal cancer. Clin Cancer Res 2008;14:8043-51
   PubMed Web of Science ®Google Scholar
• Kohno M, Hasegawa H, Miyake M, CD151 enhances cell motility and metastasis of cancer cells in the presence of focal adhesion kinase. Int J Cancer 2002;97:336-43
   Google Scholar
• Yoo SH, Lee K, Chae JY, Moon KC. CD151 expression can predict cancer progression in clear cell renal cell carcinoma. Histopathology 2011;58:191-7
   PubMed Web of Science ®Google Scholar
• Voss MA, Gordon N, Maloney S, Tetraspanin CD151 is a novel prognostic marker in poor outcome endometrial cancer. Br J Cancer 2011;104:1611-18
   PubMed Web of Science ®Google Scholar
• Tokuhara T, Hasegawa H, Hattori N, Clinical significance of CD151 gene expression in non-small cell lung cancer. Clin Cancer Res 2001;7:4109-14
   PubMed Web of Science ®Google Scholar
• Ang J, Fang BL, Ashman LK, Frauman AG. The migration and invasion of human prostate cancer cell lines involves CD151 expression. Oncol Rep 2010;24:1593-7
   Google Scholar
• Devbhandari RP, Shi GM, Ke AW, Profiling of the tetraspanin CD151 web and conspiracy of CD151/integrin beta1 complex in the progression of hepatocellular carcinoma. PLoS One 2011;6:e24901
   PubMedGoogle Scholar
• Sadej R, Romanska H, Kavanagh D, Tetraspanin CD151 regulates transforming growth factor beta signaling: implication in tumor metastasis. Cancer Res 2010;70:6059-70
   PubMed Web of Science ®Google Scholar
• Zijlstra A, Lewis J, Degryse B, The inhibition of tumor cell intravasation and subsequent metastasis via regulation of in vivo tumor cell motility by the tetraspanin CD151. Cancer Cell 2008;13:221-34
   PubMed Web of Science ®Google Scholar
• Haeuw JF, Goetsch L, Bailly C, Corvaia N. Tetraspanin CD151 as a target for antibody-based cancer immunotherapy. Biochem Soc Trans 2011;39:553-8
   Google Scholar
• Takeda Y, Kazarov AR, Butterfield CE, Deletion of tetraspanin Cd151 results in decreased pathologic angiogenesis in vivo and in vitro. Blood 2007;109:1524-32
   Google Scholar
• Zheng ZZ, Liu ZX. CD151 gene delivery increases eNOS activity and induces ECV304 migration, proliferation and tube formation. Acta Pharmacol Sin 2007;28:66-72
   Google Scholar
• Mosig RA, Lin L, Senturk E, Application of RNA-Seq transcriptome analysis: CD151 is an Invasion/Migration target in all stages of epithelial ovarian cancer. J Ovarian Res 2012;5:4
   Google Scholar
• Yang XH, Flores LM, Li Q, Disruption of laminin-integrin-CD151-focal adhesion kinase axis sensitizes breast cancer cells to ErbB2 antagonists. Cancer Res 2010;70:2256-63
   Google Scholar
• Boucheix C, Duc GH, Jasmin C, Rubinstein E. Tetraspanins and malignancy. Expert Rev Mol Med 2001;2001:1-17
   Google Scholar
• Boucheix C, Perrot JY, Mirshahi M, A new set of monoclonal antibodies against acute lymphoblastic leukemia. Leuk Res 1985;9:597-604
   Google Scholar
• Ovalle S, Gutierrez-Lopez MD, Olmo N, The tetraspanin CD9 inhibits the proliferation and tumorigenicity of human colon carcinoma cells. Int J Cancer 2007;121:2140-52
   PubMed Web of Science ®Google Scholar
• Chen S, Sun Y, Jin Z, Jing X. Functional and biochemical studies of CD9 in fibrosarcoma cell line. Mol Cell Biochem 2011;350:89-99
   Google Scholar
• Ikeyama S, Koyama M, Yamaoko M, Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J Exp Med 1993;177:1231-7
   PubMed Web of Science ®Google Scholar
• Saito Y, Tachibana I, Takeda Y, Absence of CD9 enhances adhesion-dependent morphologic differentiation, survival, and matrix metalloproteinase-2 production in small cell lung cancer cells. Cancer Res 2006;66:9557-65
   Google Scholar
• Sho M, Adachi M, Taki T, Transmembrane 4 superfamily as a prognostic factor in pancreatic cancer. Int J Cancer 1998;79:509-16
   Google Scholar
• Erovic BM, Pammer J, Hollemann D, Motility-related protein-1/CD9 expression in head and neck squamous cell carcinoma. Head Neck 2003;25:848-57
   PubMed Web of Science ®Google Scholar
• Kohmo S, Kijima T, Otani Y, Cell surface tetraspanin CD9 mediates chemoresistance in small cell lung cancer. Cancer Res 2010;70:8025-35
   Google Scholar
• Nakamoto T, Murayama Y, Oritani K, A novel therapeutic strategy with anti-CD9 antibody in gastric cancers. J Gastroenterol 2009;44:889-96
   Google Scholar
• Furuya M, Kato H, Nishimura N, Down-regulation of CD9 in human ovarian carcinoma cell might contribute to peritoneal dissemination: morphologic alteration and reduced expression of beta1 integrin subsets. Cancer Res 2005;65:2617-25
   PubMedGoogle Scholar
• Park KR, Inoue T, Ueda M, Anti-CD9 monoclonal antibody-stimulated invasion of endometrial cancer cell lines in vitro: possible inhibitory effect of CD9 in endometrial cancer invasion. Mol Hum Reprod 2000;6:719-25
   Google Scholar
• Hwang JR, Jo K, Lee Y, Upregulation of CD9 in ovarian cancer is related to the induction of TNF-alpha gene expression and constitutive NF-kappaB activation. Carcinogenesis 2012;33:77-83
   PubMed Web of Science ®Google Scholar
• Longo N, Yanez-Mo M, Mittelbrunn M, Regulatory role of tetraspanin CD9 in tumor-endothelial cell interaction during transendothelial invasion of melanoma cells. Blood 2001;98:3717-26
   PubMed Web of Science ®Google Scholar
• Wang HX, Kolesnikova TV, Denison C, The C-terminal tail of tetraspanin protein CD9 contributes to its function and molecular organization. J Cell Sci 2011;124:2702-10
   Google Scholar
• Szala S, Kasai Y, Steplewski Z, Molecular cloning of cDNA for the human tumor-associated antigen CO-029 and identification of related transmembrane antigens. Proc Natl Acad Sci USA 1990;87:6833-7
   PubMedGoogle Scholar
• Kanetaka K, Sakamoto M, Yamamoto Y, Possible involvement of tetraspanin CO-029 in hematogenous intrahepatic metastasis of liver cancer cells. J Gastroenterol Hepatol 2003;18:1309-14
   Google Scholar
• Zhou Z, Ran YL, Hu H, TM4SF3 promotes esophageal carcinoma metastasis via upregulating ADAM12m expression. Clin Exp Metastasis 2008;25:537-48
   Google Scholar
• Claas C, Seiter S, Claas A, Association between the rat homologue of CO-029, a metastasis-associated tetraspanin molecule and consumption coagulopathy. J Cell Biol 1998;141:267-80
   Google Scholar
• Nazarenko I, Rana S, Baumann A, Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation. Cancer Res 2010;70:1668-78
   PubMed Web of Science ®Google Scholar
• Tonoli H, Barrett JC. CD82 metastasis suppressor gene: a potential target for new therapeutics? Trends Mol Med 2005;11:563-70
   PubMed Web of Science ®Google Scholar
• Romanska HM, Berditchevski F. Tetraspanins in human epithelial malignancies. J Pathol 2011;223:4-14
   Google Scholar
• Jang HI, Lee H. A decrease in the expression of CD63 tetraspanin protein elevates invasive potential of human melanoma cells. Exp Mol Med 2003;35:317-23
   Google Scholar
• Chen L, Yuan D, Zhao R, Suppression of TSPAN1 by RNA interference inhibits proliferation and invasion of colon cancer cells in vitro. Tumori 2010;96:744-50
   Google Scholar
• Chen L, Zhu Y, Li H, Knockdown of TSPAN1 by RNA silencing and antisense technique inhibits proliferation and infiltration of human skin squamous carcinoma cells. Tumori 2010;96:289-95
   PubMed Web of Science ®Google Scholar
• Bennett G, Sadlier D, Doran PP, A functional and transcriptomic analysis of NET1 bioactivity in gastric cancer. BMC Cancer 2011;11:50
   Google Scholar
• Huang H, Sossey-Alaoui K, Beachy SH, Geradts J. The tetraspanin superfamily member NET-6 is a new tumor suppressor gene. J Cancer Res Clin Oncol 2007;133:761-9
   Google Scholar
• Arencibia JM, Martin S, Perez-Rodriguez FJ, Bonnin A. Gene expression profiling reveals overexpression of TSPAN13 in prostate cancer. Int J Oncol 2009;34:457-63
   PubMed Web of Science ®Google Scholar
• Prox J, Willenbrock M, Weber S, Tetraspanin15 regulates cellular trafficking and activity of the ectodomain sheddase ADAM10. Cell Mol Life Sci 2012 ; online 25 March 2012
   Google Scholar
• Xu D, Sharma C, Hemler ME. Tetraspanin12 regulates ADAM10-dependent cleavage of amyloid precursor protein. FASEB J 2009;23:3674-81
   PubMed Web of Science ®Google Scholar
• Mochizuki S, Okada Y. ADAMs in cancer cell proliferation and progression. Cancer Sci 2007;98:621-8
   PubMed Web of Science ®Google Scholar
• Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 2010;10:9-22
   PubMed Web of Science ®Google Scholar
• CLINICAL TRIALS. Available from: http://www.clinicaltrials.gov/
   Google Scholar
• Klosek SK, Nakashiro K, Hara S, CD151 regulates HGF-stimulated morphogenesis of human breast cancer cells. Biochem Biophys Res Commun 2009;379:1097-100
   Google Scholar
• Vosjan MJ, Vercammen J, Kolkman JA, Nanobodies Targeting the Hepatocyte Growth Factor: Potential New Drugs for Molecular Cancer Therapy. Mol Cancer Ther 2012;11:1017-25
   PubMed Web of Science ®Google Scholar
• Murayama Y, Shinomura Y, Oritani K, The tetraspanin CD9 modulates epidermal growth factor receptor signaling in cancer cells. J Cell Physiol 2008;216:135-43
   Google Scholar
• Odintsova E, Sugiura T, Berditchevski F. Attenuation of EGF receptor signaling by a metastasis suppressor, the tetraspanin CD82/KAI-1. Curr Biol 2000;10:1009-12
   PubMed Web of Science ®Google Scholar
• Yanez-Mo M, Gutierrez-Lopez MD, Cabanas C. Functional interplay between tetraspanins and proteases. Cell Mol Life Sci 2011;68:3323-35
   Google Scholar
• Remacle AG, Golubkov VS, Shiryaev SA, Novel MT1-MMP small-molecule inhibitors based on insights into hemopexin domain function in tumor growth. Cancer Res 2012;72:2339-49
   PubMed Web of Science ®Google Scholar
• Kolesnikova TV, Kazarov AR, Lemieux ME, Glioblastoma inhibition by cell surface immunoglobulin protein EWI-2, in vitro and in vivo. Neoplasia 2009;11:77-86. 4p following
   Google Scholar
• Colin S, Guilmain W, Creoff E, A truncated form of CD9-partner 1 (CD9P-1), GS-168AT2, potently inhibits in vivo tumour-induced angiogenesis and tumour growth. Br J Cancer 2011;105:1002-11
   Google Scholar